Siemens Healthineers appoints Kalavathi GV as Executive Director and Head of Development Center
IMT News Desk
Kala has taken office from Dileep Mangsuli, who will now lead global corporate activities in the fight against tuberculosis at Siemens HealthineersKalavathi GV (Kala) has been appointed as the head of Development Center (DC) and executive director at Siemens Healthineers India, starting July 1, 2024. In her new role, she will lead over 3,500 DC employees in India and Slovakia, driving the development of precision healthcare solutions using artificial intelligence, automation, and digital transformation for all business lines of Siemens Healthineers.Kala has an extensive track record of driving global digital transformation at large multi-national organisations. She has previously held leadership positions at Philips Healthcare and GE Healthcare and is a strong advocate of representation of senior female leaders in the Indian IT ecosystem.Kala has taken office from Dileep Mangsuli, who will now lead global corporate activities in the fight against tuberculosis at Siemens Healthineers.Peter Schardt, Chief Technology Officer, Siemens Healthineers said, “We are elated to welcome Kala who will be integral to our purpose to pioneer breakthroughs in healthcare for everyone, everywhere, sustainably. She comes with three decades of industry experience with a strong medtech and healthcare acumen, and we look forward to benefitting from her insights and ideas to strengthen our leadership in innovation. As a strong female business leader, we are confident that Kala will be a role model for our teams globally, fostering an environment of collaboration, mutual learning, inclusivity, and growth.”Kala said, “At least half of the world does not have access to essential healthcare services which has been further aggravated by a lack of trained healthcare professionals. There is a need to create intuitive healthcare solutions that can be operated by anyone. Siemens Healthineers is at the forefront of healthcare innovation by developing unique solutions that aim to provide quality patient care across the world.”
